v3.26.3
CONDENSED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Operating expenses:        
Research and development $ 2,429 $ 1,553 $ 5,457 $ 5,283
General and administrative 1,194 1,180 3,776 3,549
Total operating expenses 3,623 2,733 9,233 8,832
Loss from operations (3,623) (2,733) (9,233) (8,832)
Other income (expense):        
Interest income 82 59 253 92
Other (expense) income, net (3) 3 (5) 185
Net loss $ (3,544) $ (2,671) $ (8,985) $ (8,555)
Loss per share, basic (in dollars per share) $ (1.09) $ (1.55) $ (3.17) $ (8.29)
Loss per share, diluted (in dollars per share) $ (1.09) $ (1.55) $ (3.17) $ (8.29)
Weighted average number of shares of common stock, basic (in shares) 3,257,109 1,721,708 2,835,194 1,031,870
Weighted average number of shares of common stock, diluted (in shares) 3,257,109 1,721,708 2,835,194 1,031,870

Source